Detection and quantification of a variety of micro-and nanoscale entities, eg molecules, cells,
and particles, are crucial components of modern biomedical research, in which biosensing …

Myeloproliferative neoplasms (MPNs) are the most common underlying prothrombotic
disorder found in patients with splanchnic vein thrombosis (SVT). Clinical risk factors for …

In patients with polycythemia vera (PV), an elevated JAK2 p. V617F allele burden is
associated with indicators of more severe disease (eg, leukocytosis, splenomegaly, and …

The randomized, double‐blind, double‐dummy, phase 3b RELIEF trial evaluated
polycythaemia vera (PV)‐related symptoms in patients who were well controlled with a …

Splanchnic vein thrombosis (SVT) is one of the vascular complications of myeloproliferative
neoplasms (MPN). We designed a phase 2 clinical trial to evaluate safety and efficacy of …

Background: Patients with essential thrombocythemia (ET) are at high risk for both
thrombosis and hemorrhage. Purpose: To evaluate the risks and benefits of antithrombotic …

The genetics behind the progression of myelodysplasia to secondary acute myeloid
leukemia (sAML) is poorly understood. In this study, we profiled somatic mutations and their …

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm that arises from clonal
proliferation of hematopoietic stem cells and leads to progressive bone marrow (BM) …

Myelofibrosis (MF) is a bone marrow disorder characterized by clonal myeloproliferation,
aberrant cytokine production, extramedullary hematopoiesis, and bone marrow fibrosis …

Microparticles (MPs) are small membrane vesicles that are classified into subcategories
based on their origin, such as platelet‑derived MPs (PMPs), endothelial MPs (EMPs), red …